Advertisement
Advertisement
RVTY
Revvity, Inc.
86.48
USDSponsored
+0.97
+1.14%
Mar 16, 15:59 UTC -4
Closed
Pre-Market
86.37
-0.11
-0.13%
RVTY Earnings Reports
Positive Surprise Ratio
RVTY beat 30 of 40 last estimates.
75%
Next Report
Date of Next Report
Apr 27, 2026
Estimate for Q1 26 (Revenue/ EPS)
$716.92M
/$1.04
Implied change from Q4 25 (Revenue/ EPS)
-7.14%
/-38.82%
Implied change from Q1 25 (Revenue/ EPS)
+7.85%
/+2.97%
Revvity, Inc. earnings per share and revenue
On Feb 02, 2026, RVTY reported earnings of 1.70 USD per share (EPS) for Q4 25, beating the estimate of 1.58 USD, resulting in a 7.45% surprise. Revenue reached 772.06 million, compared to an expected 776.51 million, with a -0.57% difference. The market reacted with a -1.57% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 17 analysts forecast an EPS of 1.04 USD, with revenue projected to reach 716.92 million USD, implying an decrease of -38.82% EPS, and decrease of -7.14% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Ardent Health, Inc.
Report Date
Mar 04, 2026 For Q4 25
Estimate
$0.34
Actual
$0.32
Surprise
-8.23%
Nutex Health Inc. Common Stock
Report Date
Mar 05, 2026 For Q4 25
Estimate
$6.97
Actual
$1.61
Surprise
-76.92%
Omada Health, Inc. Common Stock
Report Date
Mar 05, 2026 For Q4 25
Estimate
-$0.05
Actual
$0.08
Surprise
+252.96%
Sonida Senior Living, Inc.
Report Date
Mar 11, 2026 For Q4 25
Estimate
-$1.25
Actual
-$1.29
Surprise
-2.41%
Enhabit, Inc.
Report Date
Mar 04, 2026 For Q4 25
Estimate
$0.14
Actual
$0.14
Surprise
-3.11%
Auna S.A.
Report Date
Mar 10, 2026 For Q4 25
Estimate
-Actual
$1.81
Surprise
-
Shoulder Innovations, Inc.
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.33
Actual
-$0.38
Surprise
-14.49%
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
The Beauty Health Company Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.06
Surprise
-14.29%
LifeMD, Inc. Common Stock
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.03
Actual
-$0.04
Surprise
-17.65%
FAQ
What were Revvity, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Revvity, Inc. reported EPS of $1.70, beating estimates by 7.45%, and revenue of $772.06M, -0.57% below expectations.
How did the market react to Revvity, Inc.'s Q4 2025 earnings?
The stock price moved down -1.57%, changed from $108.80 before the earnings release to $107.09 the day after.
When is Revvity, Inc. expected to report next?
The next earning report is scheduled for Apr 27, 2026.
What are the forecasts for Revvity, Inc.'s next earnings report?
Based on 17
analysts, Revvity, Inc. is expected to report EPS of $1.04 and revenue of $716.92M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement